The Ventures Co — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Amaryllis Therapeutics, Inc.amaryllistx.comSep 2024

Amaryllis Tx develops tissue-targeted drug delivery by mapping tissue-specific glycan signatures and designing peptides that recognize them, using in silico and in vivo screening.

AI & Machine LearningBiotechDeep TechCambridge, US

Jeongseuk Kang(Executive Officer, Director)

BoardEmmanouil Karagiannis(Director)

Co-investorsACVC Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.